Company intelligence / Profile preview

Gene Labs Technology

Colombo, Sri Lankagene.com ↗

Ownership: Private
Development stage: Other

Overview

Genelabs Medical operates as the leading private-sector provider of advanced genetic testing in Sri Lanka. It was the first private lab authorized by the Ministry of Health to conduct COVID‑19 PCR tests and has pioneered non-invasive prenatal testing (NIPT) locally. The company also performs viral genome sequencing for public health surveillance, offers oncology panels, and supports academic research with Sanger sequencing services. It maintains strict quality control standards and collaborates on R&D projects internationally.

Therapeutic areas: OncologyWomen's HealthRare DiseasesOtherInfectious Diseases
Modalities: PCR-based diagnosticsNext-generation sequencingSanger sequencing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Gene Labs Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene Labs Technology.

Explore the full profile